Xiao-yu Liu
Shiyan, 442000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
SFXN1 as a potential diagnostic and prognostic biomarker of LUAD is associated with 18F-FDG metabolic parameters.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: October 28, 2023
ECE2 is a prognostic biomarker associated with m6A modification and involved in immune infiltration of lung adenocarcinoma.
Journal: Frontiers in endocrinology
Published: August 06, 2022
Nucleophosmin 1 is a prognostic marker of gastrointestinal cancer and is associated with m6A and cuproptosis.
Journal: Frontiers in pharmacology
Published: August 03, 2022
High expression of HNRNPR in ESCA combined with 18F-FDG PET/CT metabolic parameters are novel biomarkers for preoperative diagnosis of ESCA.
Journal: Journal of translational medicine
Published: May 24, 2022
SLC2A1 is a Diagnostic Biomarker Involved in Immune Infiltration of Colorectal Cancer and Associated With m6A Modification and ceRNA.
Journal: Frontiers in cell and developmental biology
Published: January 12, 2022
Erratum: MicroRNA-101-3p suppresses cell proliferation, invasion and enhances chemotherapeutic sensitivity in salivary gland adenoid cystic carcinoma by targeting Pim-1.
Journal: American journal of cancer research
Published: December 22, 2021
Comprehensive Analysis of YTHDF1 Immune Infiltrates and ceRNA in Human Esophageal Carcinoma.
Journal: Frontiers in genetics
Published: December 15, 2021
Comprehensive Analysis of SLC17A9 and Its Prognostic Value in Hepatocellular Carcinoma.
Journal: Frontiers in oncology
Published: November 05, 2021
Corrigendum: NPM1 Is a Prognostic Biomarker Involved in Immune Infiltration of Lung Adenocarcinoma and Associated With m6A Modification and Glycolysis.
Journal: Frontiers in immunology
Published: July 31, 2021
NPM1 Is a Prognostic Biomarker Involved in Immune Infiltration of Lung Adenocarcinoma and Associated With m6A Modification and Glycolysis.
Journal: Frontiers in immunology
Published: June 14, 2021
Comprehensive Analysis of GLUT1 Immune Infiltrates and ceRNA Network in Human Esophageal Carcinoma.
Journal: Frontiers in oncology
Published: February 10, 2021
Last Updated: 09/26/2026